186 related articles for article (PubMed ID: 11519891)
21. A novel WT1 gene mutation in a patient with Wilms' tumor and 46, XY gonadal dysgenesis.
Lee DG; Han DH; Park KH; Baek M
Eur J Pediatr; 2011 Aug; 170(8):1079-82. PubMed ID: 21384108
[TBL] [Abstract][Full Text] [Related]
22. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
23. Nephrotic syndrome and end-stage renal disease with WT1 mutation detected at 3 years.
Ito S; Ikeda M; Takata A; Kikuchi H; Hata J; Honda M
Pediatr Nephrol; 1999 Nov; 13(9):790-1. PubMed ID: 10603123
[TBL] [Abstract][Full Text] [Related]
24. Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.
Schumacher VA; Jeruschke S; Eitner F; Becker JU; Pitschke G; Ince Y; Miner JH; Leuschner I; Engers R; Everding AS; Bulla M; Royer-Pokora B
J Am Soc Nephrol; 2007 Mar; 18(3):719-29. PubMed ID: 17267748
[TBL] [Abstract][Full Text] [Related]
25. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
26. An unusual presentation of Denys-Drash syndrome due to bigenic disease.
Eneman B; Mekahli D; Audrezet MP; Lerut E; Van Damme-Lombaerts R; Van den Heuvel L; Levtchenko E
Pediatrics; 2014 Jan; 133(1):e252-6. PubMed ID: 24379226
[TBL] [Abstract][Full Text] [Related]
27. Two cases of isolated diffuse mesangial sclerosis with WT1 mutations.
Hahn H; Cho YM; Park YS; You HW; Cheong HI
J Korean Med Sci; 2006 Feb; 21(1):160-4. PubMed ID: 16479084
[TBL] [Abstract][Full Text] [Related]
28. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
[TBL] [Abstract][Full Text] [Related]
29. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes).
Auber F; Lortat-Jacob S; Sarnacki S; Jaubert F; Salomon R; Thibaud E; Jeanpierre C; Nihoul-Fékété C
J Pediatr Surg; 2003 Jan; 38(1):124-9; discussion 124-9. PubMed ID: 12592634
[TBL] [Abstract][Full Text] [Related]
30. [A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy].
Yamamoto K; Santo Y; Satomura K
Nihon Jinzo Gakkai Shi; 2003; 45(1):42-6. PubMed ID: 12680320
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
[TBL] [Abstract][Full Text] [Related]
32. WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes.
Aucella F; Bisceglia L; De Bonis P; Gigante M; Caridi G; Barbano G; Mattioli G; Perfumo F; Gesualdo L; Ghiggeri GM
Pediatr Nephrol; 2006 Oct; 21(10):1393-8. PubMed ID: 16909243
[TBL] [Abstract][Full Text] [Related]
33. [Denys-Drash syndrome. Experience gathered in Erlangen illustrated by two case reports].
Zugor V; Zenker M; Dötsch J; Schrott KM; Schott GE
Urologe A; 2005 Oct; 44(10):1197-200. PubMed ID: 16003530
[TBL] [Abstract][Full Text] [Related]
34. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
[TBL] [Abstract][Full Text] [Related]
35. Gonadal effects of a mouse Denys-Drash syndrome mutation.
Patek CE; Saunders PT; Miles CG; Berry RL; Hastie ND; Sharpe RM; Hooper ML
Transgenic Res; 2005 Oct; 14(5):691-702. PubMed ID: 16245160
[TBL] [Abstract][Full Text] [Related]
36. A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1.
Viney RL; Morrison AA; van den Heuvel LP; Ni L; Mathieson PW; Saleem MA; Ladomery MR
Proteomics; 2007 Mar; 7(5):804-15. PubMed ID: 17295355
[TBL] [Abstract][Full Text] [Related]
37. A novel WT1 missense mutation presenting with Denys-Drash syndrome and cortical atrophy.
Schumacher V; Thumfart J; Drechsler M; Essayie M; Royer-Pokora B; Querfeld U; Müller D
Nephrol Dial Transplant; 2006 Feb; 21(2):518-21. PubMed ID: 16303781
[No Abstract] [Full Text] [Related]
38. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy.
Patel PR; Pappas J; Arva NC; Franklin B; Brar PC
J Pediatr Endocrinol Metab; 2013; 26(9-10):971-4. PubMed ID: 23729537
[TBL] [Abstract][Full Text] [Related]
39. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
[TBL] [Abstract][Full Text] [Related]
40. Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.
Hashimoto H; Zhang X; Zheng Y; Wilson GG; Cheng X
Nucleic Acids Res; 2016 Dec; 44(21):10165-10176. PubMed ID: 27596598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
